Nickel is an abundant carcinogenic and nephrotoxic metal whose activity leads to renal impairment. Previous studies have shown a protective effect of simultaneous vitamin C administration on acute and chronic nickel toxicity. However, very little research relating to the effect of vitamin C pretreatment in preventing nickel-induced acute nephrotoxicity is available. Therefore, the present study aimed to determine the efficiency of vitamin C (VC) pretreatment in preventing acute renal toxicity of nickel. Mice were pretreated orally with vitamin C (16.6 mg kg -1 body weight, b.w.) for seven consecutive days, prior to intraperitoneal (i.p.) administration of nickel chloride at different doses (3, 5, and 10 mg Ni kg -1 b.w.) for an exposure period of 24 hours. Thereafter, animals were killed and kidney tissue and blood samples were taken for histological examination and biochemical marker analyses. Vitamin C pretreatment alone did not alter the levels of serum kidney markers (creatinine, urea, and uric acid). However, treatment with Ni alone showed a significant increase in the levels of serum creatinine, urea, and uric acid with marked necrotic epithelial cells and infiltration by inflammatory cells in kidney sections as compared to the control group. Pretreatment with vitamin C and treatment with Ni at all doses tested for 24 hours showed a significant decrease in the levels of serum creatinine, urea, and uric acid, as well as an improvement in histological changes compared to those previously seen in the group treated with Ni alone. It is concluded that vitamin C pretreatment effectively improved renal function and tissue damage caused by nickel.
Nickel is a ubiquitous environmental pollutant used extensively in industry for various commercial processes including: production of steel, metal alloys, batteries, coins, magnets, paints, and medical implants (1, 2) . Humans are exposed to nickel by ingesting contaminated foodstuffs or inhaling cigarette smoke (3) . Nickel is transported by blood and is retained by various tissues or excreted, mainly through urine, making thus the kidney the target organ of nickel toxicity and carcinogenicity (4) (5) (6) (7) (8) . Several reports have evidenced that nickel is able to cause harmful effects to human and animal health, which increase organ cancer and injury risk (9, 10) . Nickel is a well-known cytotoxic metal that may affect various cell lines including kidney cells. It may generate reactive oxygen species, which leads to lipid peroxidation and oxidation of DNA and proteins and results in cell apoptosis and nephrotoxicity (11, 12) . Recently, antioxidant supplements have received much attention due to their antioxidant activity and a free radicalscavenging ability to quench reactive oxygen species (ROS) that induce oxidative tissue injuries and cellular damage (13) . Vitamin C (ascorbic acid or ascorbate) is a natural substance abundant in fresh fruits and vegetables (14) . It is also a powerful water-soluble antioxidant and a free radical scavenger that acts as a reducing agent, donating electrons to ROS free radicals, making these more stable and less reactive (15) . Additionally, vitamin C contributes to the restoration of depleted vitamin E and intracellular glutathione levels. This helps to actively fight oxidative stress-mediated cellular damage that leads to cell death (16) . An in vitro study (17) showed that nickel-induced oxidative stress, mediated via an increased expression of JMJD1A and the related hypoxia-response genes GLUT1 and HIF-1α in human embryonic kidney cells, was greatly reversed by ascorbate. In experimental animals, simultaneous administration of vitamin C with nickel reduced oxidative damage to the biological system by boosting the antioxidant protective system to prevent lipid peroxidation and oxidative stress in the liver (18) and the lung (19) . Furthermore, vitamin C at a single (250 mg kg -1 b.w.) and multiple doses (500 mg kg -1 b.w.) administered to mice one hour prior to cisplatin i.p. injection showed an improvement of the antioxidant status of cells, functional markers and kidney histopathological changes (20) . Similarly, KarabulutBulanet al. (21) have demonstrated that vitamin C given to rats (250 mg kg -1 a day) one hour prior to cadmium administration consecutively over eight days attenuated cadmium-induced kidney oxidative injury. It was also reported that vitamin C pretreatment protected against long-term exposure to lead-induced histopathological Correspondence to: Faouzi Dahdouh, Department of Biochemistry and Microbiology, Faculty of Sciences, Mohamed Boudiaf M'Sila University, 28000, Algeria. E-mail: faouzidahdouh@ymail.com changes in the kidney of rats (22) . To our knowledge, there is no data showing the protective effect of vitamin C pretreatment in preventing renal impairment following exposure to different doses of nickel. Therefore, the current study was designed to investigate the beneficial effect of vitamin C pretreatment against Ni-induced nephrotoxicity in male mice.
MATERIALS AND METHODS

Animals
Forty-eight male Swiss albino mice with a mean of 27.31±0.17 g (Animal Unit of "Pasteur" Institute of Algiers, Algeria) were used in this study. The animals were cared for in compliance with the guidelines of the Institutional Animal Ethical Committee Research (AFRO. No 478, 2009), as approved by the Faculty of Sciences at Annaba University, and the study was conducted in accordance with the "Guide for the Care and Use of Laboratory Animals". Mice were acclimatised to our laboratory conditions for two weeks and were thereafter weighted and divided into six equal groups. Normal mice chow (Oneb, Béjaïa, Algeria) and water were provided ad libitum throughout the period of the study.
Chemicals
Ni as nickel chloride, NiCl 2 , and vitamin C (L-ascorbic acid: C 6 H 8 O 6 ) and all other chemicals used in the experiment were purchased from Sigma Chemical Inc. (St. Louis, MO, USA).
Experimental procedure
The acclimatised animals were weighted and randomly divided into six experimental groups of six animals each. Group I (control group): mice had free access to standard diet and water ad libitum. Group II (VC): mice were treated orally with vitamin C at a dose of 16.6 g kg -1 of b.w. for seven consecutive days. Groups III (Ni3), IV (Ni5), and V (Ni10): NiCl 2 was injected i.p. at doses of 3, 5, and 10 mg Ni per kg of b.w., respectively. Animals in these groups were killed 24 h after Ni injection. Groups VI (Ni3+VC), VII (Ni5+VC), and VIII (Ni10+VC): mice were pretreated with vitamin C for seven consecutive days. On day 8, the animals received i.p. 3, 5, and 10 mg of Ni per kg b.w., respectively, over 24 h. Animals were killed after being anaesthetised with chloroform. Blood was collected into lithium heparin blood tubes and placed immediately into an ice bath until centrifugation at 3,000 g for 10 min at +4°C (Hettich Mikro 185 microliter centrifuge).
Serum samples were extracted and analysed for nephritic markers (creatinine, urea, and uric acid). The kidney was removed and processed immediately for histological examination. 
Determination of nickel concentration
The concentration of Ni in renal tissue was determined as previously described (25) . Briefly, 1 g of fresh tissue was homogenised in cold KCl using a tissue homogeniser (SCILOGEX D160). Then, the homogenate was added to 3 ml of mixed acid solution (HClO 4 /HNO 3 , 1:3, v/v). After that, the samples were digested using microwave heating, and Ni concentration was determined using a Perkin-Elmer model 5100 PC Flame Atomic Absorption Spectrophotomer (FAAS).
Biochemical assays
Serum biochemical markers: creatinine, urea, and uric acid were measured as functional markers for nephrotoxicity. They were assessed using commercially available diagnostic kits (Spinreact, Spain, ref: Creatinine-1001111, urea-1001329, and uric acid-1001011), according to the enzymatic colorimetric method and using a spectrophotometer (Jenway 6505, Jenway LTD, UK).
Histopathological evaluation
Removed kidney samples were fixed for 48 h in 10 % formalin-saline (5-6 µm thick) and dehydrated by passing successfully in different mixtures of ethyl alcohol-water, cleaned in xylene, and embedded in paraffin. Sections of the tissue (5-6 µm thick) were prepared using a rotary microtome and were stained with haematoxylin and eosin (H&E) dye, which was mounted in a neutral deparaffinated xylene medium for microscopic examinations. Microscopic images were taken by a digital camera (Leica MC190-HD, Germany) mounted on a Leica DM-1000 microscope with 40× of objective lens.
Statistical analysis
Data were analysed using the GraphpadPrism statistical program (software version 6.0). All results are given as means±SE. Comparison between group means of each parameter separately was tested by one-way ANOVA repeated measures, followed by the Protected Least Significant Difference Fisher's test (PLSD Fisher) and the level of significance was set at p<0.05.
RESULTS
Clinical signs of toxicity
At the end of the experiment, vitamin C treated mice were healthy and their behavioural patterns were comparable to controls. However, in the nickel treated groups, several clinical signs such as reduced activity, weakness, and reduced food and water intake were observed within 24 h of Ni injection. These clinical signs were almost absent in animals pretreated with vitamin C followed by Ni injection.
Ni concentration in the kidney
As seen in Figure 1 , exposure to nickel at various doses (3, 5, and 10 mg kg -1 b.w.) significantly increased its concentration in the kidney as compared to that seen in control mice (respectively, p<0.01, p<0.001, p<0.001). But when nickel and vitamin C pretreated and nickel only groups were compared, a significant decrease (p<0.001 Ni3; p<0.01 Ni5 and Ni10) of Ni level in the kidney was observed.
inflammatory cells (fig. 3C, D, and E) . The severity of tissue alterations increased commensurate to the increase in nickel doses. On the contrary, kidney histology was somewhat dependently regained in the combined treatments following the decrease in Ni doses (Fig. 4F, G, and H) .
DISCUSSION
The study provides evidence that pretreatment of mice with vitamin C is nephroprotective against acute toxicity
Figure1 Vitamin C pretreatment reduced tissue Ni concentration in the kidney, after 24 h of i.p. administration of NiCl 2 Effect of treatments on functional kidney markers
Treatment of mice with 3, 5, and 10 mg kg -1 b.w. of nickel chloride for 24 hours caused a significant increase (p<0.01) in the levels of serum nephritic markers (urea, uric acid and creatinine) when compared with control group. Similarly, vitamin C pretreatment prior to Ni administration showed a significant increase (p<0.05) in the above mentioned parameters when compared with those seen in controls. But when compared with Ni3, Ni5, and Ni10 treated groups, a significant decrease (respectively, p<0.05; p<0.01; p<0.001) was noticed (Fig. 2) .
Kidney histopathological changes
H&E kidney stained sections showed a normal structure of the renal cortex and medulla of control mice and the mice treated with vitamin C alone (Fig. 3A and B) . Ni treatment resulted in kidney histopathological changes as indicated by tubular degeneration and necrosis and infiltration by (lipids, proteins, DNA), eventually leading to renal cell death (30) . Vitamin C pretreatment prior to Ni administration reversed kidney function by normalising the increased renal parameters and histopathological changes, as well as by reducing Ni accumulation in the kidney compared to mice that received Ni alone. This is in line with what was previously reported on the simultaneous administration of vitamin C supplementation to rodents against nickelinduced renal oxidative damage (31, 32) . In parallel, oral administration of a single dose of vitamin C (150-350 mg kg -1 b.w, i.p.) to rats, six hours prior to acute administration of cisplatin (6 mg kg -1 b.w., i.p.), for four consecutive days showed remarkable protection against kidney damage induced by cisplatin (33) . Also, Shaban El-Neweshy and Said El-Sayed (22) have investigated the nephroprotective effect of vitamin C (20 mg kg -1 b.w., oral route) pretreatment against renal histopathological changes following oral administration of lead to rats, 30 min after vitamin C administration.
These results suggested that vitamin C could strongly enhance the cellular antioxidant capacity to counteract ROS-mediated free radical reactions before they reached their cellular targets. As reported, vitamin C reduces the absorption of dietary nickel in intestine (34), suggesting of nickel at all tested doses (3, 5, and 10 mg kg -1 b.w.) through a substantial decrease in the concentration of serum urea, uric acid, and creatinine and the concentration of Ni in renal tissue. Furthermore, the expressed histologic damage scores were lower, showing minimal tubular generation, necrosis, and infiltration by inflammatory cells that were induced by nickel treatment.The nephrotoxic effect of Ni is observed in a significant increase in the serum level of urea and creatinine, which may result in a decrease in reabsorption at renal epithelium and disruption of glomerular filtration rate. This increases the risk of renal failure (26) . The measurements of creatinine, urea, and uric acid are considered a tool in the clinical diagnosis of renal dysfunction following acute and chronic oxidative kidney injury (27, 28) . The increased level of Ni in the kidney that was observed after Ni treatment could be explained by high affinity of metallothionein, a metal binding protein for Ni (29) . The adverse effects of Ni on kidney function are potentially related to oxidative stress and overproduction of free radicals that can cause oxidation of biomolecules that vitamin C may act as a chelating agent of nickel leading to a lower cellular uptake of nickel, protecting consequently against kidney oxidative injury.
In conclusion, pretreatment with vitamin C effectively ameliorated kidney dysfunction by decreasing the serum functional kidney markers (urea, creatinine, and uric acid) and the concentration of Ni in the kidney of mice caused by acute administration of various doses (3, 5, and 10 mg kg -1 ) of nickel. Thus, administration of vitamin C prior to nickel treatment provides an efficient protection against Niinduced acute nephrotoxicity in mice. Further studies need to ascertain the protective effect of pretreatment with more doses of vitamin C against Ni-induced kidney oxidative stress, and therefore these should focus on the nephroprotective effect of vitamin C in a dose dependent manner.
Prethodna terapija vitaminom C štiti od niklom izazvane nefrotoksičnosti u miševa
Nikal je sveprisutan kancerogeni i nefrotoksični metal čije djelovanje dovodi do oštećenja bubrežne funkcije. Rezultati prethodnih istraživanja dokazali su zaštitni učinak istodobne terapije vitaminom C na akutnu i kroničnu toksičnost izazvanu niklom. Međutim, vrlo je malo istraživanja o učinku prethodne terapije vitaminom C radi sprječavanja niklom izazvane akutne nefrotoksičnosti. Stoga se ovim ispitivanjem nastojala utvrditi učinkovitost prethodne terapije vitaminom C (VC) u sprječavanju akutne bubrežne toksičnosti izazvane niklom. Prije intraperitonealnog (IP) ubrizgavanja različitih doza (3, 5 i 10 mg Ni kg -1 tjelesne težine) nikal klorida u razdoblju izlaganja od 24 sata, miševi su sedam dana uzastopce dobivali oralnu terapiju vitaminom C (16,6 mg kg -1 tjelesne težine). Nakon toga životinje su usmrćene, a bubrežno tkivo i uzorci krvi uzeti su radi histološke obrade i analize biokemijskih markera. U miševa koji su dobivali samo terapiju vitaminom C, serumske razine bubrežnih markera (kreatinin, urea i mokraćna kiselina) nisu bile promijenjene. Međutim, tretiranje samo niklom dovelo je do značajnog povećanja razina kreatinina, ureje i mokraćne kiseline te do značajnog broja nekrotičnih epitelnih stanica i infiltracije upalnih stanica u presjecima bubrega u usporedbi s kontrolnom skupinom. Prethodna terapija vitaminom C i tretiranje niklom u svim navedenim dozama tijekom 24 sata doveli su do značajnog smanjenja razina kreatinina, ureje i mokraćne kiseline u serumu te do poboljšanja histoloških promjena u usporedbi sa skupinom koja je tretirana samo niklom. Zaključuje se da prethodna terapija vitaminom C učinkovito poboljšava bubrežnu funkciju i oštećenje tkiva uzrokovano niklom.
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